These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32138500)

  • 1. lncRNA CASC2 suppresses the growth of hemangioma cells by regulating miR-18a-5p/FBXL3 axis.
    Dai YX; Qiu MK; Wang SQ; Pan C; Wang Y; Ou JM
    J Biol Regul Homeost Agents; 2020; 34(1):49-56. PubMed ID: 32138500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated lncRNA CASC2 May Inhibit Malignant Melanoma Development Through Regulating miR-18a-5p/RUNX1.
    Zhang Y; Qian W; Feng F; Cao Q; Li Y; Hou Y; Zhang L; Fan J
    Oncol Res; 2019 Feb; 27(3):371-377. PubMed ID: 29422114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA cancer susceptibility candidate 2 regulates the function of human fibroblast-like synoviocytes via the microRNA-18a-5p/B-cell translocation gene 3 signaling axis in rheumatoid arthritis.
    Ye Z; Wei L; Yin X; Li H; Qin G; Li S; Peng T; Liu B; Zhao S; Zhuo Q
    Bioengineered; 2022 Feb; 13(2):3240-3250. PubMed ID: 35045800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CASC2 inhibits the growth, migration, and invasion of thyroid cancer cells through sponging miR-18a-5p/FIH1 axis.
    Liu QY; Gao LY; Xu L; Zhang XL; Zhang LJ; Gong XL; Luo SB; Zhao R; Cheng RC
    Kaohsiung J Med Sci; 2021 Apr; 37(4):268-275. PubMed ID: 33336500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CASC2 targeting miR-18a suppresses glioblastoma cell growth, metastasis and EMT
    Wang J; Qin C; Zhong C; Wen Y; Ke S; Liao BO
    J Biosci; 2020; 45():. PubMed ID: 32975234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
    Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
    Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.
    Zheng P; Dong L; Zhang B; Dai J; Zhang Y; Wang Y; Qin S
    Histochem Cell Biol; 2019 Oct; 152(4):281-291. PubMed ID: 31352515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CASC2 is involved in the development of chronic obstructive pulmonary disease
    Liu P; Zhang H; Zeng H; Meng Y; Gao H; Zhang M; Zhao L
    Ther Adv Respir Dis; 2021; 15():17534666211028072. PubMed ID: 34266334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Molecular Mechanism of LncRNA-CASC2/miR-155-5p/APC Axis Regulating the Progression of Non-Hodgkin Lymphoma].
    Zheng CJ; Wu ZM; Wang YS; Hou YX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1939-1945. PubMed ID: 33283723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA NEAT1 promotes the progression of hemangioma via the miR-361-5p/VEGFA pathway.
    Yu X; Liu X; Wang R; Wang L
    Biochem Biophys Res Commun; 2019 May; 512(4):825-831. PubMed ID: 30928097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
    Wang J; Jia J; Zhou L
    Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-Coding RNA
    Kang L; Sun J; Liu J; Xu F; Zhu Q; Shi X
    Cell J; 2022 Nov; 24(11):665-672. PubMed ID: 36377216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a.
    Ba Z; Gu L; Hao S; Wang X; Cheng Z; Nie G
    Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29194827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR-362-5p/Nf-κB axis.
    Zhao L; Zhang Y; Zhang Y
    J Cell Physiol; 2018 Oct; 233(10):6661-6670. PubMed ID: 29319182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA CASC2 inhibits tumorigenesis via the miR-181a/PLXNC1 axis in melanoma.
    Wang Z; Wang X; Zhou H; Dan X; Jiang L; Wu Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):263-272. PubMed ID: 29514220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma.
    Peng L; Liu YH; Nie S; Gao M
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8367-8376. PubMed ID: 32894543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
    Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z
    Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis.
    Dai W; Mu L; Cui Y; Li Y; Chen P; Xie H; Wang X
    Med Sci Monit; 2019 Jan; 25():730-738. PubMed ID: 30681073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
    Fan JC; Zeng F; Le YG; Xin L
    J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.